Phenotypic characterization of two Ancylostoma caninum isolates with different susceptibilities to the anthelmintic pyrantel

Antimicrobial Agents and Chemotherapy

Volumn 52, Issue 11, 2008, Pages 3980-3986

  Kopp, Steven R ^a   Coleman, Glen T ^a   McCarthy, James S ^a   Kotze, Andrew C ^b  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b CSIRO   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BEPHENIUM HYDROXYNAPHTHOATE; LEVAMISOLE; NICOTINE; NICOTINIC RECEPTOR; PYRANTEL;

ANCYLOSTOMA CANINUM; ANTIBIOTIC RESISTANCE; ARTICLE; DRUG POTENCY; IC 50; LARVA; NONHUMAN; PRIORITY JOURNAL;

ANCYLOSTOMA; ANCYLOSTOMIASIS; ANIMALS; ANTINEMATODAL AGENTS; BEPHENIUM COMPOUNDS; DOGS; DRUG RESISTANCE; FEMALE; HUMANS; LARVA; LEVAMISOLE; NICOTINE; NICOTINIC AGONISTS; PHENOTYPE; PYRANTEL; RECEPTORS, NICOTINIC;

EID: 55849123010     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00523-08     Document Type: Article

References (30)

1. Bethony, J., S. Brooker, M. Albonico, S. M. Geiger, A. Loukas, D. Diemert, and P. J. Hotez. 2006. Soil-transmitted helminth infections: ascariasis, trichuriasis, and hookworm. Lancet 367:1521-1532.
2. Bethony, J., A. Loukas, M. Smout, S. Brooker, S. Mendez, J. Plieskatt, G. Goud, M. E. Bottazzi, B. Zhan, Y. Wang, A. Williamson, S. Lustigman, R. Correa-Oliveira, S. Xiao, and P. J. Hotez. 2005. Antibodies against a secreted protein from hookworm larvae reduce the intensity of hookworm infection in humans and vaccinated laboratory animals. FASEB J. 19:1743-1745.
3. Coles, G. C., S. N. Brown, and C. M. Trembath. 1999. Pyrantel-resistant large strongyles in racehorses. Vet. Rec. 145:408.
4. Drudge, J. H., E. T. Lyons, S. C. Tolliver, S. R. Lowry, and E. H. Fallon. 1988. Piperazine resistance in population-B equine strongyles: a study of selection in thoroughbreds in Kentucky from 1966 through 1983. Am. J. Vet. Res. 49:986-994.
5. Howes, H. L., Jr. 1972. trans-1,4,5,6-Tetrahydro-2-(3- hydroxystyryl)-1-methyl pyrimidine (CP-14,445), a new antiwhipworm agent. Proc. Soc. Exp. Biol. Med. 139:394-398.
6. Jackson, R., D. Lance, and K. Townsend. 1987. Isolation of anthelmintic resistant Ancylostoma caninum. N. Z. Vet. J. 35:215-216.
7. Jacobs, D. E., A. Arakawa, C. H. Courtney, M. A. Gemmell, J. W. McCall, G. H. Myers, and O. Vanparijs. 1994. World Association for the Advancement of Veterinary Parasitology (W.A.A.V.P.) guidelines for evaluating the efficacy of anthelmintics for dogs and cats. Vet. Parasitol. 52:179-202.
8. Jones, A. K., and D. B. Sattelle. 2004. Functional genomics of the nicotinic acetylcholine receptor gene family of the nematode, Caenorhabditis elegans. Bioessays 26:39-49.
9. Kaminsky, R., P. Ducray, M. Jung, R. Clover, L. Rufener, J. Bouvier, S. S. Weber, A. Wenger, S. Wieland-Berghausen, T. Goebel, N. Gauvry, F. Pautrat, T. Skripsky, O. Froelich, C. Komoin-Oka, B. Westlund, A. Sluder, and P. Maser. 2008. A new class of anthelmintics effective against drug-resistant nematodes. Nature 452:176-180.
10. Klein, J. B., R. E. Bradley, Sr., and D. P. Conway. 1978. Anthelmintic efficacy of pyrantel pamoate against the roundworm, Toxocara canis, and the hookworm, Ancylostoma caninum, in dogs. Vet. Med. Small Anim. Clin. 73:1011-1013.
11. Kopp, S. R., G. T. Coleman, J. S. McCarthy, and A. C. Kotze. 2008. Application of in vitro anthelmintic sensitivity assays to canine parasitology: detecting resistance to pyrantel in Ancylostoma caninum. Vet. Parasitol. 152:284-293.
12. Kopp, S. R., A. C. Kotze, J. S. McCarthy, and G. T. Coleman. 2007. High-level pyrantel resistance in the hookworm Ancylostoma caninum. Vet. Parasitol. 143:299-304.
13. Kopp, S. R., A. C. Kotze, J. S. McCarthy, R. J. Traub, and G. T. Coleman. 2007. Pyrantel in small animal medicine: 30 years on. Vet. J. [Epub ahead of print.] PMID 17720556.
14. Kotze, A. C., S. Clifford, J. O'Grady, J. M. Behnke, and J. S. McCarthy. 2004. An in vitro larval motility assay to determine anthelmintic sensitivity for human hookworm and Strongyloides species. Am. J. Trop. Med. Hyg. 71: 608-616.
15. Kotze, A. C., P. A. Stein, and R. J. Dobson. 1999. Investigation of intestinal nematode responses to naphthalophos and pyrantel using a larval development assay. Int. J. Parasitol. 29:1093-1099.
16. Martin, R. J. 1997. Modes of action of anthelmintic drugs. Vet. J. 154:11-34.
17. Martin, R. J., C. L. Clark, S. M. Trailovic, and A. P. Robertson. 2004. Oxantel is an N-type (methyridine and nicotine) agonist not an L-type (levamisole and pyrantel) agonist: classification of cholinergic anthelmintics in Ascaris. Int. J. Parasitol. 34:1083-1090.
18. Martin, R. J., and A. P. Robertson. 2007. Mode of action of levamisole and pyrantel, anthelmintic resistance, E153 and Q57. Parasitology 134:1093-1104.
19. Petersen, M. B., J. Craven, H. Bjorn, and P. Nansen. 2000. Use of a migration assay for the separation of adult pyrantel-susceptible and -resistant Oesophagostomum dentatum. Vet. Parasitol. 91:141-145.
20. Reynoldson, J. A., J. M. Behnke, L. J. Pallant, M. G. Macnish, F. Gilbert, S. Giles, R. J. Spargo, and R. C. Thompson. 1997. Failure of pyrantel in treatment of human hookworm infections (Ancylostoma duodenale) in the Kimberley region of north west Australia. Acta Trop. 68:301-312.
21. Richmond, J. E., and E. M. Jorgensen. 1999. One GABA and two acetylcholine receptors function at the C. elegans neuromuscular junction. Nat. Neurosci. 2:791-797.
22. Robertson, A. P., H. E. Bjorn, and R. J. Martin. 1999. Resistance to levamisole resolved at the single-channel level. FASEB J. 13:749-760.
23. Robertson, A. P., C. L. Clark, T. A. Burns, D. P. Thompson, T. G. Geary, S. M. Trailovic, and R. J. Martin. 2002. Paraherquamide and 2-deoxyparaherquamide distinguish cholinergic receptor subtypes in Ascaris muscle. J. Pharmacol. Exp. Ther. 302:853-860.
24. Robinson, M., F. Hooke, and K. E. Iverson. 1976. Efficacy of oxantel pamoate and pyrantel pamoate in combination against Trichuris Vulpis, Ancylostoma caninum and Toxocara canis in dogs. Aust. Vet. Pract. 6:173-176.
25. Roepstorff, A., H. Bjorn, and P. Nansen. 1987. Resistance of Oesophagostomum spp. in pigs to pyrantel citrate. Vet. Parasitol. 24:229-239.
26. Sangster, N. C., C. W. Davis, and G. H. Collins. 1991. Effects of cholinergic drugs on longitudinal contraction in levamisole-susceptible and -resistant Haemonchus contortus. Int. J. Parasitol. 21:689-695.
27. Sangster, N. C., and D. F. Mettrick. 1987. Effects of cholinergic drugs on muscle contraction in Moniliformis moniliformis (Acanthocephala). J. Parasitol. 73:998-1004.
28. Sangster, N. C., J. Song, and J. Demeler. 2005. Resistance as a tool for discovering and understanding targets in parasite neuromusculature. Parasitology 131:S179-S190.
29. Todd, A. C., J. Crowley, and P. Scholl. 1975. Critical tests with pyrantel pamoate against internal parasites in dogs from Wisconsin. Vet. Med. Small Anim. Clin. 70:936-939.
30. Williamson, S. M., T. K. Walsh, and A. J. Wolstenholme. 2007. The Cys-loop ligand-gated ion channel gene family of Brugia malayi and Trichinella spiralis: a comparison with Caenorhabditis elegans. Invertebrate Neurosci. 7:219-226.